title: Phase III clinical trials that integrate treatment and biomarker evaluation.
authors.affiliation: National Cancer Institute, Bethesda, MD, USA. freidlinb@ctep.nci.nih.gov
authors.forename: Boris
authors.initials: B
authors.lastname: Freidlin
authors.forename: Zhuoxin
authors.initials: Z
authors.lastname: Sun
authors.forename: Robert
authors.initials: R
authors.lastname: Gray
authors.forename: Edward L
authors.initials: EL
authors.lastname: Korn
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009369:Neoplasms / Q000737:chemistry / Q000188:drug therapy*; D012107:Research Design
chemical_list: D014408:Biomarkers, Tumor